Director records verified

Chand Rameshbhai Kanabar

Named in 26 filings across 2 BSE-listed companies since 2026-02 — most recently at Accretion Nutraveda Ltd (2026-10).
Records through 2026-10-10 · refreshed as new filings arrive
Seen in filings at (from BSE disclosures)
Accretion Nutraveda Ltd
Board change filings ×5
20 filings · 2026-02 – 2026-10
Riddhi Display Equipments Ltd
Board change filings ×5
6 filings · 2026-02 – 2026-04
Documented roles (from public records)
Accretion Pharmaceuticals Ltd
Independent Non-Executive Director (Committee Chairman) · current
Curis Lifesciences Ltd
Independent Director (appointed; later resigned citing personal reasons per BSE filing) · ~2024-2025
Golden Sparrow Consultancy Private Limited
director · current
Common questions (from the filings record)
Who is Chand Rameshbhai Kanabar in BSE filings?
Chand Rameshbhai Kanabar is named in 26 filings across 2 BSE-listed companies since 2026-02 — most recently at Accretion Nutraveda Ltd (2026-10). Records through 2026-10-10, from public exchange disclosures.
Which companies is Chand Rameshbhai Kanabar named in?
Accretion Nutraveda Ltd (Board change filings ×5) — 20 filings, 2026-02 to 2026-10; Riddhi Display Equipments Ltd (Board change filings ×5) — 6 filings, 2026-02 to 2026-04.
What documented roles does Chand Rameshbhai Kanabar hold?
From public records: Accretion Pharmaceuticals Ltd — Independent Non-Executive Director (Committee Chairman), current; Curis Lifesciences Ltd — Independent Director (appointed; later resigned citing personal reasons per BSE filing), ~2024-2025; Golden Sparrow Consultancy Private Limited — director, current.
Track record, connections and full analysis — on the Bench
The Bench shows this person's documented history, their connections across listed companies, and what happened after their filings.
Special Situations Bench a Humdinger HQ product
Compiled from public exchange disclosures and public records. situations.humdingerhq.ai is not a SEBI-registered research analyst; nothing here is investment advice. Corrections: via Humdinger HQ.